Farther Finance Advisors LLC Acquires 8,061 Shares of Teladoc Health, Inc. $TDOC

Farther Finance Advisors LLC lifted its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC) by 424.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,960 shares of the health services provider’s stock after acquiring an additional 8,061 shares during the period. Farther Finance Advisors LLC’s holdings in Teladoc Health were worth $87,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in TDOC. Golden State Wealth Management LLC boosted its stake in Teladoc Health by 102.6% during the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider’s stock valued at $27,000 after purchasing an additional 1,690 shares during the last quarter. National Bank of Canada FI raised its stake in shares of Teladoc Health by 79.4% in the first quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider’s stock worth $28,000 after purchasing an additional 1,581 shares during the last quarter. SVB Wealth LLC bought a new position in shares of Teladoc Health in the first quarter valued at approximately $37,000. BI Asset Management Fondsmaeglerselskab A S bought a new position in shares of Teladoc Health in the first quarter valued at approximately $50,000. Finally, Quantitative Investment Management LLC purchased a new position in shares of Teladoc Health during the first quarter valued at approximately $82,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Wall Street Analysts Forecast Growth

TDOC has been the subject of a number of analyst reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Teladoc Health in a research report on Saturday, September 27th. Mizuho assumed coverage on shares of Teladoc Health in a research note on Friday, July 25th. They issued a “neutral” rating and a $10.00 target price for the company. Finally, Evercore ISI increased their target price on shares of Teladoc Health from $7.00 to $8.00 and gave the company an “in-line” rating in a report on Wednesday, July 9th. Six analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $9.80.

Teladoc Health Stock Performance

NYSE TDOC opened at $9.01 on Friday. The company has a market capitalization of $1.59 billion, a PE ratio of -7.57 and a beta of 1.90. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67. Teladoc Health, Inc. has a 52-week low of $6.35 and a 52-week high of $15.21. The company has a 50-day simple moving average of $7.66 and a 200 day simple moving average of $7.59.

Teladoc Health (NYSE:TDOC) last issued its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.08. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The firm had revenue of $631.90 million for the quarter, compared to analyst estimates of $621.91 million. During the same period in the previous year, the company posted ($0.38) earnings per share. The business’s revenue was down 1.6% on a year-over-year basis. Teladoc Health has set its Q3 2025 guidance at -0.350–0.200 EPS. FY 2025 guidance at -1.350–1.000 EPS. On average, research analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.